Dog Heartworm Disease: Prevention, Treatment, and Welfare Considerations

Heartworm disease causes significant suffering in infected dogs and is almost entirely preventable through monthly prophylaxis — making prevention a straightforward welfare priority.

Key Facts

Dirofilaria immitis, the heartworm parasite, is transmitted by mosquitoes and causes progressive pulmonary and cardiac disease in infected dogs — without treatment, heartworm disease is fatal
Heartworm is endemic throughout the United States and many tropical and subtropical regions globally — the geographic range has expanded with climate change increasing mosquito habitat
Monthly preventive medications (ivermectin-based, milbemycin-based, or other macrocyclic lactone compounds) are highly effective when given consistently — prevention is the most important welfare intervention
Treatment of established heartworm infection requires a prolonged, expensive, and restrictive protocol: typically multiple injections of melarsomine over months, strict exercise restriction, and monitoring for potentially fatal pulmonary embolism during worm die-off
The welfare cost of treating established heartworm infection is significant: dogs must be strictly rested for 6-8 weeks during treatment — a significant behavioral welfare cost on top of the physical welfare cost of active infection
Access to prevention is a significant welfare equity issue: heartworm preventives require veterinary prescription in the US, creating cost and access barriers for low-income households, particularly in endemic regions
The American Heartworm Society recommends year-round prevention even in regions with cold winters — geographic risk is higher than many owners realize and risk period is extending with climate change

Welfare Considerations

Heartworm prevention is one of the clearest welfare cases in companion animal medicine: an inexpensive, highly effective monthly medication prevents a disease that causes months of suffering and requires an expensive, restrictive treatment protocol. The welfare calculus is simple — prevention costs a fraction of treatment and avoids all the suffering of active heartworm infection. The equity barrier is real: low-income households in endemic regions face prescription access requirements that create barriers to prevention, resulting in higher heartworm prevalence in economically disadvantaged communities. Veterinary access programs, low-cost prevention clinics, and over-the-counter prevention availability reform would reduce this equity gap with direct welfare benefit for thousands of dogs annually.

What You Can Do

Maintain consistent year-round heartworm prevention for all dogs in or traveling through endemic regions — consistent monthly dosing is essential for effectiveness
Establish a relationship with a veterinarian who can prescribe prevention annually with heartworm testing — preventive care is far less expensive than treatment
Support low-cost veterinary clinics in underserved communities that provide heartworm testing and affordable prevention for dogs in high-risk populations
Test all dogs before starting prevention if they have not been consistently protected — treating a heartworm-positive dog with prevention without testing can cause severe reactions
Advocate for better prevention access policies including longer prescription validity and recognition of veterinary telemedicine prescriptions that reduce cost barriers to prevention